首页> Cancers> Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b-4 and/or Gleason 9-10.

Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b-4 and/or Gleason 9-10.

导出 OA

翻译打印收藏纠错

第一作者： Hideya,Yamazaki

第一单位： Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.

作者： Hideya,Yamazaki ^[1] ; Gen,Suzuki ^[1] ; Koji,Masui ^[1] ; Norihiro,Aibe ^[1] ; Daisuke,Shimizu ^[1] ; Takuya,Kimoto ^[1] ; Kei,Yamada ^[1] ; Koji,Okihara ^[2] ; Takashi,Ueda ^[2] ; Tsukasa,Narukawa ^[2] ; Takumi,Shiraishi ^[2] ; Atsuko,Fujihara ^[2] ; Ken,Yoshida ^[3] ; Satoaki,Nakamura ^[3] ; Takashi,Kato ^[4] ; Yasutoshi,Hashimoto ^[4] ; Haruumi,Okabe ^[4]

作者单位： Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. ^[1] Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. ^[2] Department of Radiology, Kansai Medical University, Hirakata 573-1010, Japan. ^[3] Department of Radiology, Ujitakeda Hospital, Uji-City, Kyoto 611-0021, Japan. ^[4]

关键词 Gleason 9–10 T3b–4 brachytherapy boost prostate cancer radiotherapy very high-risk

DOI 10.3390/cancers14122976

PMID 35740639

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交